Trader’s Buzzer: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.25% or -0.08 points to reach at $32.52 during previous trading session. The stock’s price fluctuated within the range of $32.33 – $32.78 during previous trading session. A total of 20,274,122 shares exchanged hands, whereas the company’s average trading volume stands at 26.85M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $196.86B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 46.17.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 14 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is -0.99% whereas its distance from 50 day simple moving average is 1.48% along with -2.14% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.43% below from the 52-week high mark of $36.72 and +18.28% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -2.87% in the past one week and plunged -0.94% during previous one month drive, the stock went up 0.26% during past quarter. In the last six months the stock’s performance fell -9.93% while yearly performance of the company advanced 8.49%. The company’s year to date (YTD) performance is at 0.12%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.49, along with its weekly and monthly volatility of 1.56%, 1.24% respectively. Beta value of the stock stands at 0.94.

The company’s price to free cash flow for trailing twelve months is 111.08. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Investor’s Alert: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.09% or -0.03 points to reach at $33.44 during previous trading session. The stock’s price fluctuated within the range of $33.32 – $33.66 during previous trading session. A total of 19,368,800 shares exchanged hands, whereas the company’s average trading volume stands at 6.07B shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $202.87B and most recently 26.22M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 63.69.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 14 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 2.12% whereas its distance from 50 day simple moving average is 4.60% along with 0.80% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -8.92% below from the 52-week high mark of $36.72 and +21.63% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 1.33% in the past one week and soared 8.08% during previous one month drive, the stock went up 0.49% during past quarter. In the last six months the stock’s performance fell -6.03% while yearly performance of the company advanced 11.70%. The company’s year to date (YTD) performance is at 2.96%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.44, along with its weekly and monthly volatility of 1.13%, 1.28% respectively. Beta value of the stock stands at 0.94.

The company’s price to free cash flow for trailing twelve months is 114.38. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Investor’s Watch: Notable Mover: Pfizer Inc (NYSE:PFE)

Pfizer Inc (NYSE:PFE) share price plunged -0.39% or -0.13 points to reach at $33.48 during previous trading session. The stock’s price fluctuated within the range of $33.34 – $33.70 during previous trading session. A total of 17.47M shares exchanged hands, whereas the company’s average trading volume stands at 23.28M shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $202.38B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 67.75.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53 while the most conventional predicts the target price at $30.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc (NYSE:PFE)’s distance from 20 day simple moving average is 3% whereas its distance from 50 day simple moving average is 4.91% along with 1.05% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc (NYSE:PFE) shares were trading -8.81% below from the 52-week high mark of $36.72 and +21.77% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 8/1/16 and 52-week low price on 2/8/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 3.05% in the past one week and soared 6.08% during previous one month drive, the stock went up 0.49% during past quarter. In the last six months the stock’s performance plunged -5.61% while yearly performance of the company advanced 10.66%.The company’s year to date (YTD) performance is at 3.08%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.45, along with its weekly and monthly volatility of 1.19%, 1.40% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 114.11. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Analysts Activity: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) plunged -0.39% during previous trade, a total of 17.47M shares exchanged hands compared with its average trading volume of 23.58M shares whereas its relative volume is 0.67. The stock has a market capitalization of $215.12B along with 6.07B outstanding shares. Stock’s intraday price range hit the peak level of $33.70 and touched the lowest level of $33.34.

Most recently Pfizer Inc. (NYSE:PFE)’s price target was revised on 01/3/17 and according to 20 analysts stock’s price will reach at $37.65 during 52 weeks with standard deviation of 5.70. Stock’s minimum price target estimates has been figured out at $30 while the maximum price target forecast is established at $53, if we look at the price target with an optimistic approach it has upside potential of 58% from its latest closing price of $33.48.

Historically, if we look at price target revisions, three week ago Pfizer Inc. (NYSE:PFE)’s price target was revised on 11/25/16 by the analysts, however the bullish price estimates of the stock set at $53 while the bearish estimates kept at $33 over the next one year. Stock’s 52-week target was retained at $38.46, the estimates indicates a standard deviation of 5.32.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.06. ABR value is precisely based on brokerage recommendations, where out of 17 brokerage recommendations 8 rate Pfizer Inc. (NYSE:PFE) stock a Strong Buy, 0 rate the stocks of the company a Buy, 9 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 11/2/16 the stock of Pfizer Inc. (NYSE:PFE) downgraded by Argus from Buy to HoldNeutral. However previously on 10/13/16 it was downgraded by Jefferies from Buy to Hold. A research note issued on 11/25/15 the stock was upgraded by Sun Trust Rbsn Humphrey from Reduce to Neutral.

Pfizer Inc. (NYSE:PFE) performance over the past one year soared 10.66% whereas its year to date (YTD) performance indicated a bullish trend of 3.08%. During the last six months the stock slipped -5.61%. Quarterly performance of the company shows optimistic momentum of 0.49% while its last one month trend is positive with 6.08%. Stock’s weekly performance expressed up trend of 3.05%.

The company’s price sits 4.91% above from its 50-day moving average of $32.21 and 1.05% far from the stock’s 200-day moving average which is $33.76. Pfizer Inc. (NYSE:PFE)’s shares are currently trading -8.81% away from the 52-week high price of $36.72 and +21.77% far from the 52-week low price of $27.49.

According to consensus agreement of 16 analysts Pfizer Inc. (NYSE:PFE) will report earnings per share of $0.5 in their quarterly report and it is expected to announce the company’s results on 1/31/17 Before Market Open. For the current quarter the company has high EPS estimates of $0.54 in contradiction of low EPS estimates of $0.47. However a year ago for the same quarter the company has reported $0.53 EPS. Current year EPS projections for Pfizer Inc. (NYSE:PFE) set at $2.42 according to the sentiments of 19 analysts, while its lowest earnings estimates are $2.38 and highest earnings estimates are $2.46.

According to 13 analysts, Pfizer Inc. (NYSE:PFE)’s revenue estimates for the current quarter are $13.67B meanwhile the company has high revenue estimates of $14.53B in contradiction of low revenue estimates of $12.95B. For the current year the company’s revenue estimates are $52.91B compared to low analyst estimates of $52.15B and high estimates of $53.73B according to the projection of 16 analysts.

Stock in Limelight: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.03% or -0.01 points to reach at $32.48 during previous trading session. The stock’s price fluctuated within the range of $32.31 – $32.60 during previous trading session. A total of 18.87M shares exchanged hands, whereas the company’s average trading volume stands at 23.86M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $197.04B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 56.31.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 0.87% whereas its distance from 50 day simple moving average is 2.05% along with -1.73% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.54% below from the 52-week high mark of $36.72 and +18.13% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.43% in the past one week and soared 1.06% during previous one month drive, the stock went down -3.15% during past quarter. In the last six months the stock’s performance fell -7.01% while yearly performance of the company advanced 4.42%. The company’s year to date (YTD) performance is at 4.42%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.45, along with its weekly and monthly volatility of 0.82%, 1.44% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 110.63. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Investor’s Watch: Notable Mover: Pfizer Inc (NYSE:PFE)

Pfizer Inc (NYSE:PFE) share price soared 0.43% or 0.14 points to reach at $32.48 during previous trading session. The stock’s price fluctuated within the range of $32.36 – $32.56 during previous trading session. A total of 10.79M shares exchanged hands, whereas the company’s average trading volume stands at 197.95M shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $197.95B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 54.16.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53 while the most conventional predicts the target price at $30.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc (NYSE:PFE)’s distance from 20 day simple moving average is 1.28% whereas its distance from 50 day simple moving average is 2.08% along with -1.52% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc (NYSE:PFE) shares were trading -11.54% below from the 52-week high mark of $36.72 and +18.13% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 8/1/16 and 52-week low price on 2/8/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -1.10% in the past one week and soared 3.37% during previous one month drive, the stock went down -2.49% during past quarter. In the last six months the stock’s performance plunged -2.14% while yearly performance of the company advanced 3.34%.The company’s year to date (YTD) performance is at 4.42%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.51, along with its weekly and monthly volatility of 1.08%, 1.50% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 110.63. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock on Trader’s Radar: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.19% or -0.06 points to reach at $32.34 during previous trading session. The stock’s price fluctuated within the range of $32.05 – $32.43 during previous trading session. A total of 18,582,400 shares exchanged hands, whereas the company’s average trading volume stands at 26.40M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $193.56B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 52.60.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 0.98% whereas its distance from 50 day simple moving average is 1.62% along with -1.89% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.92% below from the 52-week high mark of $36.72 and +17.62% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -1.25% in the past one week and soared 3.22% during previous one month drive, the stock went down -4.66% during past quarter. In the last six months the stock’s performance fell -3.05% while yearly performance of the company advanced 3.08%. The company’s year to date (YTD) performance is at 3.97%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.54, along with its weekly and monthly volatility of 1.21%, 1.60% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 110.15. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Analysts Review on Price Target Estimates: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) plunged -1.37% during previous trade, a total of 18.74M shares exchanged hands compared with its average trading volume of 31.65M shares whereas its relative volume is 0.71. The stock has a market capitalization of $196.73B along with 6.07B outstanding shares. Stock’s intraday price range hit the peak level of $32.93 and touched the lowest level of $32.33.

Most recently Pfizer Inc. (NYSE:PFE)’s price target was revised on 12/19/16 and according to 20 analysts stock’s price will reach at $37.65 during 52 weeks with standard deviation of 5.70. Stock’s minimum price target estimates has been figured out at $30 while the maximum price target forecast is established at $53, if we look at the price target with an optimistic approach it has upside potential of 61% from its latest closing price of $32.40.

Historically, if we look at price target revisions, three week ago Pfizer Inc. (NYSE:PFE)’s price target was revised on 11/25/16 by the analysts, however the bullish price estimates of the stock set at $53 while the bearish estimates kept at $33 over the next one year. Stock’s 52-week target was retained at $38.46, the estimates indicates a standard deviation of 5.32.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.07. ABR value is precisely based on brokerage recommendations, where out of 17 brokerage recommendations 8 rate Pfizer Inc. (NYSE:PFE) stock a Strong Buy, 0 rate the stocks of the company a Buy, 9 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 11/2/16 the stock of Pfizer Inc. (NYSE:PFE) downgraded by Argus from Buy to HoldNeutral. However previously on 10/13/16 it was downgraded by Jefferies from Buy to Hold. A research note issued on 11/25/15 the stock was upgraded by Sun Trust Rbsn Humphrey from Reduce to Neutral.

Pfizer Inc. (NYSE:PFE) performance over the past one year soared 3.40% whereas its year to date (YTD) performance indicated a bullish trend of 4.17%. During the last six months the stock slipped -4.61%. Quarterly performance of the company shows declining momentum of -4.18% while its last one month trend is positive with 2.63%. Stock’s weekly performance expressed down trend of -1.28%.

The company’s price sits 1.78% above from its 50-day moving average of $31.74 and -1.66% away from the stock’s 200-day moving average which is $33.92. Pfizer Inc. (NYSE:PFE)’s shares are currently trading -11.75% away from the 52-week high price of $36.72 and +17.84% far from the 52-week low price of $27.49.

According to consensus agreement of 16 analysts Pfizer Inc. (NYSE:PFE) will report earnings per share of $0.5 in their quarterly report and it is expected to announce the company’s results on 2/7/17. For the current quarter the company has high EPS estimates of $0.54 in contradiction of low EPS estimates of $0.47. However a year ago for the same quarter the company has reported $0.53 EPS. Current year EPS projections for Pfizer Inc. (NYSE:PFE) set at $2.42 according to the sentiments of 19 analysts, while its lowest earnings estimates are $2.38 and highest earnings estimates are $2.46.

According to 13 analysts, Pfizer Inc. (NYSE:PFE)’s revenue estimates for the current quarter are $13.67B meanwhile the company has high revenue estimates of $14.53B in contradiction of low revenue estimates of $12.95B. For the current year the company’s revenue estimates are $52.91B compared to low analyst estimates of $52.15B and high estimates of $53.73B according to the projection of 16 analysts.

Stock in the Spotlight: Notable Mover: Pfizer Inc (NYSE:PFE)

Pfizer Inc (NYSE:PFE) share price soared 0.03% or 0.02 points to reach at $32.85 during previous trading session. The stock’s price fluctuated within the range of $32.57 – $32.88 during previous trading session. A total of 25.07M shares exchanged hands, whereas the company’s average trading volume stands at 31.85M shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $199.28B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 60.29.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53 while the most conventional predicts the target price at $30.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc (NYSE:PFE)’s distance from 20 day simple moving average is 2.95% whereas its distance from 50 day simple moving average is 3.16% along with -0.23% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc (NYSE:PFE) shares were trading -10.53% below from the 52-week high mark of $36.72 and +19.48% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 8/1/16 and 52-week low price on 2/8/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.06% in the past one week and soared 4.35% during previous one month drive, the stock went down -3.22% during past quarter. In the last six months the stock’s performance plunged -2.95% while yearly performance of the company advanced 5.03%.The company’s year to date (YTD) performance is at 5.61%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.57, along with its weekly and monthly volatility of 1.23%, 1.63% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 111.89. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock to Keep Your Eyes on: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price soared 0.27% or +0.09 points to reach at $32.84 during previous trading session. The stock’s price fluctuated within the range of $32.52 – $32.94 during previous trading session. A total of 36,843,862 shares exchanged hands, whereas the company’s average trading volume stands at 25.93M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $198.86B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 59.87.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.85. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 15 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 3.32% whereas its distance from 50 day simple moving average is 3.08% along with -0.14% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -10.56% below from the 52-week high mark of $36.72 and +19.44% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 3.60% in the past one week and soared 2.75% during previous one month drive, the stock went down -1.43% during past quarter. In the last six months the stock’s performance fell -3.06% while yearly performance of the company advanced 5.42%. The company’s year to date (YTD) performance is at 5.58%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.70, along with its weekly and monthly volatility of 1.71%, 1.69% respectively. Beta value of the stock stands at 0.89.

The company’s price to free cash flow for trailing twelve months is 111.85. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.